Publication & Citation Trends
Publications
0 total
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor OA
Cited by 65
Semantic Scholar
Design-Rules for Stapled Alpha-Helical Peptides with On-Target In Vivo Activity: Application to Mdm2/X dual antagonists OA
Cited by 1
Semantic Scholar
A high‐throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell‐based assays OA
Cited by 4
Semantic Scholar
Bioactivation of GPR40 Agonist MK-8666: Formation of Protein Adducts in Vitro from Reactive Acyl Glucuronide and Acyl CoA Thioester. OA
Cited by 18
Semantic Scholar
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMs.
Cited by 8
Semantic Scholar
Design and Synthesis of Novel, Selective GPR40 AgoPAMs. OA
Cited by 25
Semantic Scholar
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40
Cited by 173
Semantic Scholar
Integrated Physiology/Obesity OA
Cited by 0
Semantic Scholar
Research Topics
Cholinesterase and Neurodegenerative Diseases
(14)
Chemical Synthesis and Analysis
(13)
Cancer therapeutics and mechanisms
(13)
Alzheimer's disease research and treatments
(11)
Computational Drug Discovery Methods
(11)
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Centre National de la Recherche Scientifique
Chimie ParisTech
University of Pittsburgh
United States Military Academy